Amneal Pharmaceuticals

AMRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.787 B

$18.14 +0.39%

Close of 7 Aug 2026

Revenue

$3.02B

#918 by revenue

Earnings

$72.1M

#1436 by earnings

Shares outstanding

319,353,919

Latest filing cover page

P/E ratio

80.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#54Kiniksa Pharmaceuticals InternationalKNSA$5.93B
#55Ligand PharmaceuticalsLGND$5.88B
#56Amneal PharmaceuticalsAMRX$5.79B
#57Travere TherapeuticsTVTX$5.78B
#58GrifolsGRFS$5.46B

Where these numbers come from

Share counts and financials for Amneal Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.